Powell R J, Machiedo G W, Rush B F, Dikdan G S
Department of Surgery UMDNJ-New Jersey Medical School, Newark.
Am Surg. 1991 Feb;57(2):86-8.
Sepsis remains a leading cause of death in the surgical intensive care unit (SICU) patient following major surgery or trauma. Recent work has demonstrated that oxygen-free radicals (OFR) generated during sepsis contribute to the pathogenesis of this syndrome. The purpose of this study was to evaluate the effect of various new free radical scavengers on survival in sepsis. A total of 85 male Sprague-Dawley rats were placed into one of the following treatment groups.
cecal ligation and puncture (CLP); PRE-AT: pretreatment with alpha-tocopherol (AT) 10 mg/100 gm SC x 3 days, and 5 mg/100 gm IV prior to CLP; AT: 20 mg/100 gm at time of CLP and 4 hours following CLP; U74006F: (21-aminosteroid which inhibits lipid peroxidation) 3 mg/kg IV at the time of and 4 hours following CLP; U78517F: (alpha-tocopherol analogue) 3 mg/kg at the time of and 4 hours following CLP. Survival was determined at various time points up to 72 hours. Pretreatment with AT resulted in improved survival, whereas the novel OFR scavengers U78517F and U74006F significantly improved survival and were efficacious without pretreatment. It was concluded that OFR scavengers can improve survival in sepsis.
脓毒症仍然是大手术或创伤后外科重症监护病房(SICU)患者死亡的主要原因。最近的研究表明,脓毒症期间产生的氧自由基(OFR)促成了该综合征的发病机制。本研究的目的是评估各种新型自由基清除剂对脓毒症患者生存率的影响。总共85只雄性Sprague-Dawley大鼠被分为以下治疗组之一。
盲肠结扎穿孔术(CLP);α-生育酚预处理组(PRE-AT):在CLP前3天皮下注射10mg/100gα-生育酚(AT),并在CLP前静脉注射5mg/100g;AT组:在CLP时及CLP后4小时静脉注射20mg/100g;U74006F组:(抑制脂质过氧化的21-氨基类固醇)在CLP时及CLP后4小时静脉注射3mg/kg;U78517F组:(α-生育酚类似物)在CLP时及CLP后4小时静脉注射3mg/kg。在长达72小时的不同时间点测定生存率。AT预处理可提高生存率,而新型OFR清除剂U78517F和U74006F可显著提高生存率,且无需预处理即可有效。得出的结论是,OFR清除剂可提高脓毒症患者的生存率。